Background: The American Heart Association’s PREVENT risk equations estimate both 10-year and 30-year risks for cardiovascular disease (CVD) in younger adults aged 30–59 years. Recent analyses show that many younger adults have low short-term (10-year) risk but high long-term (30-year) predicted CVD risk. However, it is unclear which risk factors can be prioritized for the largest population benefit to mitigate long-term CVD risk within this PREVENT risk strata. Objective: We quantified the contribution of risk factors for incident CVD in younger adults classified as having low short-term risk but high long-term risk by PREVENT within the national REGARDS prospective cohort. Methodology: We included participants 45-59 years of age in the REGARDS cohort without prevalent atherosclerotic CVD (ASCVD) or heart failure (HF) recruited in 2003-07 from the continental United States. We estimated the sex-specific prevalence, age and race adjusted hazard ratios accounting for competing risk of non-CVD death, and the population attributable risk percent (PAR%) for incident CVD associated with hypertension, dyslipidemia, obesity, diabetes, current smoking, chronic kidney disease CKD, high-sensitivity C-reactive protein (hs-CRP) ≥ 3 mg/dL, and a family history of ASCVD. The prevalence and PAR% were calculated for the low 10-year (< 12.5%)/high 30-year (≥30%) risk group of interest by PREVENT, and stratified by sex. A low 10-year total CVD risk threshold (<12.5%) was defined by a risk percentile method consistent with a low 10-year ASCVD risk (<7.5%). Results: Among 6,761 participants, 1,421 (21.0%) had low 10-year/high 30-year PREVENT risk (703 women and 718 men). Overall, there were 566 incident CVD events over a median follow-up of 14.4 years, of which there 194 incident CVD events occurred in the low 10-year/high 30-year PREVENT risk group. Within the low 10-year/high 30-year PREVENT risk group, the highest PAR% for incident CVD were for hypertension (65%), diabetes (45%), and obesity (35%) in women, in comparison to hypertension (40%), hs-CRP ≥ 3 mg/dL (26%), and dyslipidemia (25%) in men (Table 1). Conclusion: Hypertension is the largest contributor to incident CVD among younger adults with low short-term but high-long term predicted CVD risk, and supports the role of early primary prevention strategies focusing on treating hypertension in this population.
Satish et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: